Condition

Covid19 (3)

SARS-CoV Infection (1)

Stroke Hemorrhagic (1)

Stroke, Acute (1)

Stroke, Ischemic (1)

Overall Status

Recruiting (2)

Active, not recruiting (1)

Phase

phase 2/phase 3 (1)

phase 3 (1)

Sponsor

Cambridge University Hospitals NHS Foundation Trust (1)

King's College Hospital NHS Trust (1)

Novavax (1)

Collaborator

National Institute for Health Research, United Kingdom (2)

Addenbrookes Charitable Trust (1)

Department of Health and Human Services (1)

GlaxoSmithKline (1)

Kidney Research UK (KRUK) (1)

LifeArc (1)

UNION therapeutics (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Observational (1)

Covid19

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

SARS-CoV Infection, Covid19 Trial in Mexico, Puerto Rico, United States (SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination

Active, not recruiting

SARS-CoV Infection
Covid19

SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
+5 more

Birmingham, Alabama
+155 more

Dec 16, 2022

Covid19 Trial in United Kingdom (Niclosamide, Placebo, Ciclesonide)

Recruiting

Covid19

Niclosamide
+3 more

Cambridge, Cambridgeshire, United Kingdom
+34 more

Feb 20, 2022

COVID-19 Stroke Apical Lung Examination Study

Recruiting

Covid19
+3 more

Bath, United Kingdom
+11 more

May 26, 2021